Edward A. Sausville

Linking the growth inhibition response from the National Cancer Institute's anticancer screen to gene expression levels and other molecular target data

Anders Wallqvist, Alfred A. Rabow, Robert H. Shoemaker, 2003, Bioinform..

A direct interaction between NQO1 and a chemotherapeutic dimeric naphthoquinone

Edward A. Sausville, Edwin Pozharski, E. Sausville, 2016, BMC Structural Biology.

P1-12-20: The Safety and Tolerability of Vorinostat in Combination with Lapatinib in Advanced Solid Tumors.

Edward A. Sausville, Saranya Chumsri, Vered Stearns, 2011 .

Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines

Edward A. Sausville, Walter E. Laug, E. Sausville, 2003, Cancer Chemotherapy and Pharmacology.

The Chk1 Protein Kinase and the Cdc25C Regulatory Pathways Are Targets of the Anticancer Agent UCN-01*

Edward A. Sausville, E. Sausville, P. O'Connor, 2000, The Journal of Biological Chemistry.

Identification of compounds with preferential inhibitory activity against low-Nm23-expressing human breast carcinoma and melanoma cell lines

Edward A. Sausville, Melinda G. Hollingshead, M. Grever, 1997, Nature Medicine.